• CMS Proposes Eliminating 5 MIPS Measures


    The Centers for Medicare & Medicaid Services’ (CMS) proposed 2022 Medicare Physician Fee Schedule calls for the elimination of five quality measures used to assess performance in the Merit-Based Incentive Payment System (MIPS).

    In the proposed rule, CMS proposes to remove measures which many IRIS® (Intelligent Research in Sight) Registry ophthalmic practices utilize for MIPS. They include:

    • Measure 14: Age-Related Macular Degeneration (AMD): Dilated Macular Examination
    • Measure 19: Diabetic Retinopathy: Communication With the Physician Managing Ongoing Diabetes Care
    • Measure 137: Melanoma: Continuity of Care — Recall System
    • Measure 154: Falls: Risk Assessment
    • Measure 317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

    If adopted as proposed, the CMS fee schedule would reduce the reporting options for many ophthalmologists. We’re planning to respond to the proposal with a strong objection to the measures’ elimination. You can respond as well by officially submitting your comments in one of two ways:

    • Submit comments electronically, through regulations.gov.
    • Written comments must be mailed to:
      Centers for Medicare & Medicaid Services
      Department of Health and Human Services
      Attention: CMS-1751-P
      P.O. Box 8016
      Baltimore, MD 21244-8016

      Express or overnight mail to:
      Centers for Medicare & Medicaid Services
      Department of Health and Human Services
      Attention: CMS-1751-P
      Mail Stop C4-26-05
      7500 Security Blvd.
      Baltimore, MD 21244-1850

    Make sure to mail early so comments can be received before the comment period ends. Electronic comments are due by 11:59 p.m. ET on Sept. 13, and mailed comments must be received by 5 p.m. ET, Sept. 13.